Find a clinical trial
A clinical trial is a research study that people can join. Some test a new treatment. Some test a new way to use a treatment we already have. Joining one is always your choice.
How to think about a clinical trial covers what taking part involves, when to ask, and what the phases mean.
Talk to your care team before you contact a trial. They know your history and can tell you whether a trial is worth your time. Nothing on this page is medical advice, and we are not part of any trial.
Trials near you
Enter your ZIP code to see open trials with a site within 50 miles. We use your ZIP only to run that search. We do not store it.
This box works for US ZIP codes only. Outside the US, use the country filter below to see trials in your country. It will not tell you how far away they are.
Trials by countries
Showing 478 trials. Trials we know are closed are left out. This list is the brain tumor trials we track, not every trial on ClinicalTrials.gov. The search above looks at all of them.
-
Testing whether focused radiation can be left out after surgery for cancer that spread to the brain
This study looks at skipping the usual radiation after brain surgery in people who take cancer medicine that works inside the brain.
-
Testing NST-628 in adults with grade 4 glioma that came back
This study tests a drug called NST-628 in adults whose grade 4 glioma has returned.
-
Testing focused radiation with and without an extra edge for cancer that spread to the brain
This study tests whether a tighter radiation target works as well for tumors that spread to the brain.
-
Testing two kinds of MRI scans to find problems in the brain and spinal cord
This study tests whether two MRI scans can help doctors find and understand problems in the brain and spinal cord.
-
Testing a special MRI scan to tell dead tissue from returning glioma
This study tests whether a special MRI scan can tell treatment damage apart from a tumor that has come back.
-
Testing whether repeated MRI scans can help guide radiation for high grade glioma
This study looks at whether extra brain scans during treatment can help doctors adjust the plan.
-
A Study Asking Brain Cancer Patients About Care Through Video Visits
This study asks people with brain cancer how they feel about getting care through telemedicine.
-
Testing abexinostat with low-dose Temodar for glioma that has come back
This trial tests a new drug called abexinostat together with the chemo pill Temodar for brain tumors that have come back.
-
Studying Brain Scans in People Who Need Brain Surgery for a Brain Lesion
This study uses brain scans to learn why one kind of scan can give misleading results near a brain lesion.
-
Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training
From the trial team: The VIBRANT (Vision Improvement through Behavioral Rehabilitation And Neuroplasticity Training) study is a prospective, double-blind, crossover design (within-subject) in participants with homonymous hemianopia-a type of visual field loss resulting from damage to the post-chiasmatic visual pathways.
-
Testing tarlatamab with temozolomide for teens and adults with brain and spinal cord tumors
This study tests whether two drugs used together are safe and whether they help against certain brain tumors.
-
Home-based Vision Rehabilitation Guided by Brain Imaging
From the trial team: The BRIGHT (Behavioral Rehabilitation Through Image-Guided Home-based Training) study aims to evaluate the effectiveness of image-guided, home-based perceptual training at improving visual performance in individuals with visual field loss.
-
Selumetinib compared with carboplatin and vincristine for low-grade glioma
This study compares a pill called selumetinib with the usual chemotherapy for a slow-growing brain tumor.
-
Testing the drug CBL0137 in people whose tumors came back or did not respond to treatment
This study is testing a drug called CBL0137 in people with solid tumors, brain and spine tumors, or lymphoma that came back or kept growing.
-
Testing the drug mirdametinib for children and young adults with low-grade glioma
This study tests a drug called mirdametinib in young people with a brain tumor called low-grade glioma.
-
Testing a leukemia drug, with or without sildenafil, in brain tumors
This trial tests whether a drug used for leukemia can reach brain tumors.
-
Finding a Safe Dose of Rhenium-186 Treatment for Young People With Ependymoma or High-Grade Glioma
This study tests how much of a new treatment young people with hard-to-treat brain tumors can safely take.
-
Testing SX-682 with proton radiation for cancer that has spread to the lining of the brain and spine
This study is testing whether a drug called SX-682, given with a type of radiation, is safe for people whose melanoma or lung cancer has spread to the lining of the brain and spine.
-
A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment
From the trial team: Many clinical trials evaluating cancer treatments require patients to undergo testing for specific molecular markers as part of eligibility screening, typically using immunohistochemistry or sequencing.
-
Protecting bone marrow to allow stronger chemotherapy for glioblastoma after surgery
This study tests shielding bone marrow so glioblastoma patients can get stronger chemo.
Trial information comes from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. We copy it as it is published there and do not change it. Always check the trial's own page for the latest.